SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021109
Filing Date
2022-08-04
Accepted
2022-08-04 16:36:04
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20220630.htm   iXBRL 10-Q 1729124
2 EX-10.2 lyel-20220630x10qxexx102.htm EX-10.2 35823
3 EX-31.1 lyel-20220630x10qxexx311.htm EX-31.1 9609
4 EX-31.2 lyel-20220630x10qxexx312.htm EX-31.2 9581
5 EX-32.1 lyel-20220630x10qxexx321.htm EX-32.1 4992
6 EX-32.2 lyel-20220630x10qxexx322.htm EX-32.2 4950
12 lyel-20220630_g1.jpg GRAPHIC 614118
  Complete submission text file 0001628280-22-021109.txt   9020452

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20220630.xsd EX-101.SCH 53945
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20220630_cal.xml EX-101.CAL 64574
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20220630_def.xml EX-101.DEF 276156
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20220630_lab.xml EX-101.LAB 656958
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20220630_pre.xml EX-101.PRE 440965
64 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20220630_htm.xml XML 1201652
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 221137244
SIC: 2834 Pharmaceutical Preparations